A Content Analysis of Cannabis Company Adherence to Marketing Requirements in Four States

In November 2021, Washington State passed Initiative Measure No. 502 (I-502) and Colorado passed Amendment 64, both of which legalized recreational, non-medical cannabis use for persons ages 21 and over. As of 2021, a total of 17 states have passed legislation allowing adult non-medical use of cannabis (National Conference of State Legislatures, 2021). Laws such as I-502 have led to concern about increased youth exposure and access to cannabis, which may be an unintended consequence of expanding adult access. Adolescents are a crucial at-risk population for cannabis use: rates of use among adolescents are approximately 15% for past-30-day use and 30% for lifetime use (Johnston et al., 2018). Consequences of adolescent cannabis use include academic difficulties such as dropping out of school, psychiatric impairment including memory loss, and progression to other drugs (Buckner et al., 2010; Green et al., 2010, 2017; Scott et al., 2018).

To read the full study published in the Journal of Studies on Alcohol and Drugs, click here:

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top